nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP2C18—prostate cancer	0.185	0.441	CbGaD
Diphenhydramine—SLC22A1—prostate cancer	0.151	0.36	CbGaD
Diphenhydramine—CYP2C19—prostate cancer	0.0829	0.198	CbGaD
Diphenhydramine—SLC22A2—Estradiol—prostate cancer	0.0263	0.0723	CbGbCtD
Diphenhydramine—CYP2C19—Bicalutamide—prostate cancer	0.0252	0.0693	CbGbCtD
Diphenhydramine—CYP2C19—Nilutamide—prostate cancer	0.0252	0.0693	CbGbCtD
Diphenhydramine—CYP2B6—Estrone—prostate cancer	0.0237	0.0653	CbGbCtD
Diphenhydramine—SLC22A1—Estradiol—prostate cancer	0.0228	0.0628	CbGbCtD
Diphenhydramine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0212	0.0582	CbGbCtD
Diphenhydramine—CYP2C9—Nilutamide—prostate cancer	0.0209	0.0576	CbGbCtD
Diphenhydramine—CYP2C9—Bicalutamide—prostate cancer	0.0209	0.0576	CbGbCtD
Diphenhydramine—CYP2C19—Flutamide—prostate cancer	0.0209	0.0574	CbGbCtD
Diphenhydramine—CYP1A2—Flutamide—prostate cancer	0.0192	0.053	CbGbCtD
Diphenhydramine—CYP2D6—Bicalutamide—prostate cancer	0.0191	0.0527	CbGbCtD
Diphenhydramine—CYP2D6—Abiraterone—prostate cancer	0.0159	0.0436	CbGbCtD
Diphenhydramine—CYP1A2—Estrone—prostate cancer	0.0139	0.0383	CbGbCtD
Diphenhydramine—CYP2C9—Estrone—prostate cancer	0.0125	0.0345	CbGbCtD
Diphenhydramine—PTGS1—Etoposide—prostate cancer	0.0117	0.0321	CbGbCtD
Diphenhydramine—CYP2C9—Capecitabine—prostate cancer	0.0095	0.0261	CbGbCtD
Diphenhydramine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0091	0.0251	CbGbCtD
Diphenhydramine—CYP2C19—Estradiol—prostate cancer	0.00866	0.0238	CbGbCtD
Diphenhydramine—CYP1A2—Estradiol—prostate cancer	0.00799	0.022	CbGbCtD
Diphenhydramine—CYP2C19—Prednisone—prostate cancer	0.00745	0.0205	CbGbCtD
Diphenhydramine—CYP2C9—Estradiol—prostate cancer	0.0072	0.0198	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—prostate cancer	0.00607	0.0167	CbGbCtD
Diphenhydramine—CYP1A2—Etoposide—prostate cancer	0.00522	0.0144	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—prostate cancer	0.00293	0.00807	CbGbCtD
Diphenhydramine—CYP2C19—urine—prostate cancer	0.00167	0.12	CbGeAlD
Diphenhydramine—CYP1A2—urine—prostate cancer	0.00136	0.098	CbGeAlD
Diphenhydramine—CYP2C9—urine—prostate cancer	0.00129	0.093	CbGeAlD
Diphenhydramine—CYP2D6—urine—prostate cancer	0.000969	0.0698	CbGeAlD
Diphenhydramine—CHRM2—prostate gland—prostate cancer	0.00079	0.0569	CbGeAlD
Diphenhydramine—SLC22A2—renal system—prostate cancer	0.000748	0.0539	CbGeAlD
Diphenhydramine—SLC22A5—prostate gland—prostate cancer	0.000539	0.0388	CbGeAlD
Diphenhydramine—SLC22A1—renal system—prostate cancer	0.000529	0.0381	CbGeAlD
Diphenhydramine—HRH1—prostate gland—prostate cancer	0.000457	0.0329	CbGeAlD
Diphenhydramine—SLC22A5—seminal vesicle—prostate cancer	0.000456	0.0328	CbGeAlD
Diphenhydramine—PTGS1—prostate gland—prostate cancer	0.000423	0.0305	CbGeAlD
Diphenhydramine—Cyclizine—SULT1E1—prostate cancer	0.00042	0.0974	CrCbGaD
Diphenhydramine—SLC22A5—renal system—prostate cancer	0.000367	0.0265	CbGeAlD
Diphenhydramine—SLC22A5—urethra—prostate cancer	0.000361	0.026	CbGeAlD
Diphenhydramine—PTGS1—seminal vesicle—prostate cancer	0.000358	0.0258	CbGeAlD
Diphenhydramine—HRH1—epithelium—prostate cancer	0.000336	0.0242	CbGeAlD
Diphenhydramine—CYP1A2—renal system—prostate cancer	0.000333	0.024	CbGeAlD
Diphenhydramine—CYP2B6—renal system—prostate cancer	0.000319	0.023	CbGeAlD
Diphenhydramine—PTGS1—epithelium—prostate cancer	0.000311	0.0224	CbGeAlD
Diphenhydramine—HRH1—urethra—prostate cancer	0.000306	0.0221	CbGeAlD
Diphenhydramine—PTGS1—renal system—prostate cancer	0.000288	0.0208	CbGeAlD
Diphenhydramine—SLC22A5—testis—prostate cancer	0.000237	0.0171	CbGeAlD
Diphenhydramine—CYP2D6—renal system—prostate cancer	0.000237	0.0171	CbGeAlD
Diphenhydramine—CYP2B6—testis—prostate cancer	0.000206	0.0149	CbGeAlD
Diphenhydramine—HRH1—testis—prostate cancer	0.000201	0.0145	CbGeAlD
Diphenhydramine—PTGS1—testis—prostate cancer	0.000186	0.0134	CbGeAlD
Diphenhydramine—Dimetacrine—ACHE—prostate cancer	0.000181	0.0419	CrCbGaD
Diphenhydramine—SLC22A5—lymph node—prostate cancer	0.000172	0.0124	CbGeAlD
Diphenhydramine—Tamoxifen—SULT1A1—prostate cancer	0.00017	0.0395	CrCbGaD
Diphenhydramine—CYP2D6—testis—prostate cancer	0.000153	0.011	CbGeAlD
Diphenhydramine—HRH1—lymph node—prostate cancer	0.000146	0.0105	CbGeAlD
Diphenhydramine—Bifonazole—CYP17A1—prostate cancer	0.000142	0.0329	CrCbGaD
Diphenhydramine—Neuropathy peripheral—Docetaxel—prostate cancer	0.000142	0.00148	CcSEcCtD
Diphenhydramine—Convulsion—Mitoxantrone—prostate cancer	0.000141	0.00148	CcSEcCtD
Diphenhydramine—Chills—Etoposide—prostate cancer	0.00014	0.00146	CcSEcCtD
Diphenhydramine—Tachycardia—Estradiol—prostate cancer	0.00014	0.00146	CcSEcCtD
Diphenhydramine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000139	0.00146	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Estradiol—prostate cancer	0.000138	0.00145	CcSEcCtD
Diphenhydramine—Rash—Ethinyl Estradiol—prostate cancer	0.000138	0.00145	CcSEcCtD
Diphenhydramine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000138	0.00145	CcSEcCtD
Diphenhydramine—Headache—Ethinyl Estradiol—prostate cancer	0.000137	0.00144	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Capecitabine—prostate cancer	0.000137	0.00143	CcSEcCtD
Diphenhydramine—Sweating increased—Prednisone—prostate cancer	0.000136	0.00142	CcSEcCtD
Diphenhydramine—PTGS1—lymph node—prostate cancer	0.000135	0.00974	CbGeAlD
Diphenhydramine—Agranulocytosis—Docetaxel—prostate cancer	0.000135	0.00141	CcSEcCtD
Diphenhydramine—Confusional state—Mitoxantrone—prostate cancer	0.000134	0.00141	CcSEcCtD
Diphenhydramine—Photosensitivity—Doxorubicin—prostate cancer	0.000133	0.00139	CcSEcCtD
Diphenhydramine—Agranulocytosis—Capecitabine—prostate cancer	0.00013	0.00137	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Mitoxantrone—prostate cancer	0.00013	0.00137	CcSEcCtD
Diphenhydramine—Nausea—Ethinyl Estradiol—prostate cancer	0.00013	0.00136	CcSEcCtD
Diphenhydramine—Tachycardia—Mitoxantrone—prostate cancer	0.00013	0.00136	CcSEcCtD
Diphenhydramine—Asthenia—Goserelin—prostate cancer	0.000129	0.00135	CcSEcCtD
Diphenhydramine—Insomnia—Estradiol—prostate cancer	0.000129	0.00135	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000129	0.00135	CcSEcCtD
Diphenhydramine—Paraesthesia—Estradiol—prostate cancer	0.000128	0.00134	CcSEcCtD
Diphenhydramine—Asthenia—Conjugated Estrogens—prostate cancer	0.000128	0.00134	CcSEcCtD
Diphenhydramine—Somnolence—Estradiol—prostate cancer	0.000127	0.00133	CcSEcCtD
Diphenhydramine—Anorexia—Mitoxantrone—prostate cancer	0.000127	0.00133	CcSEcCtD
Diphenhydramine—Diplopia—Epirubicin—prostate cancer	0.000126	0.00132	CcSEcCtD
Diphenhydramine—Dyspepsia—Estradiol—prostate cancer	0.000126	0.00132	CcSEcCtD
Diphenhydramine—Hypotension—Mitoxantrone—prostate cancer	0.000125	0.0013	CcSEcCtD
Diphenhydramine—Decreased appetite—Estradiol—prostate cancer	0.000124	0.0013	CcSEcCtD
Diphenhydramine—Diarrhoea—Goserelin—prostate cancer	0.000123	0.00129	CcSEcCtD
Diphenhydramine—Fatigue—Estradiol—prostate cancer	0.000123	0.00129	CcSEcCtD
Diphenhydramine—Constipation—Estradiol—prostate cancer	0.000122	0.00128	CcSEcCtD
Diphenhydramine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000122	0.00128	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Prednisone—prostate cancer	0.000122	0.00128	CcSEcCtD
Diphenhydramine—Vertigo—Etoposide—prostate cancer	0.000122	0.00128	CcSEcCtD
Diphenhydramine—Paraesthesia—Mitoxantrone—prostate cancer	0.00012	0.00125	CcSEcCtD
Diphenhydramine—Dizziness—Goserelin—prostate cancer	0.000119	0.00125	CcSEcCtD
Diphenhydramine—Somnolence—Mitoxantrone—prostate cancer	0.000118	0.00124	CcSEcCtD
Diphenhydramine—Dizziness—Conjugated Estrogens—prostate cancer	0.000118	0.00124	CcSEcCtD
Diphenhydramine—Feeling abnormal—Estradiol—prostate cancer	0.000118	0.00123	CcSEcCtD
Diphenhydramine—Convulsion—Etoposide—prostate cancer	0.000118	0.00123	CcSEcCtD
Diphenhydramine—Dyspepsia—Mitoxantrone—prostate cancer	0.000117	0.00123	CcSEcCtD
Diphenhydramine—Tinnitus—Capecitabine—prostate cancer	0.000117	0.00122	CcSEcCtD
Diphenhydramine—Diplopia—Doxorubicin—prostate cancer	0.000117	0.00122	CcSEcCtD
Diphenhydramine—Chills—Docetaxel—prostate cancer	0.000116	0.00122	CcSEcCtD
Diphenhydramine—Decreased appetite—Mitoxantrone—prostate cancer	0.000116	0.00121	CcSEcCtD
Diphenhydramine—Fatigue—Mitoxantrone—prostate cancer	0.000115	0.0012	CcSEcCtD
Diphenhydramine—Vomiting—Goserelin—prostate cancer	0.000115	0.0012	CcSEcCtD
Diphenhydramine—Constipation—Mitoxantrone—prostate cancer	0.000114	0.00119	CcSEcCtD
Diphenhydramine—Rash—Goserelin—prostate cancer	0.000114	0.00119	CcSEcCtD
Diphenhydramine—Dermatitis—Goserelin—prostate cancer	0.000114	0.00119	CcSEcCtD
Diphenhydramine—Vomiting—Conjugated Estrogens—prostate cancer	0.000114	0.00119	CcSEcCtD
Diphenhydramine—Urticaria—Estradiol—prostate cancer	0.000114	0.00119	CcSEcCtD
Diphenhydramine—Headache—Goserelin—prostate cancer	0.000113	0.00118	CcSEcCtD
Diphenhydramine—Rash—Conjugated Estrogens—prostate cancer	0.000113	0.00118	CcSEcCtD
Diphenhydramine—Chills—Capecitabine—prostate cancer	0.000113	0.00118	CcSEcCtD
Diphenhydramine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000113	0.00118	CcSEcCtD
Diphenhydramine—Headache—Conjugated Estrogens—prostate cancer	0.000112	0.00117	CcSEcCtD
Diphenhydramine—Confusional state—Etoposide—prostate cancer	0.000112	0.00117	CcSEcCtD
Diphenhydramine—Feeling abnormal—Mitoxantrone—prostate cancer	0.00011	0.00115	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Etoposide—prostate cancer	0.000109	0.00114	CcSEcCtD
Diphenhydramine—Tachycardia—Etoposide—prostate cancer	0.000108	0.00113	CcSEcCtD
Diphenhydramine—Nausea—Goserelin—prostate cancer	0.000107	0.00112	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Etoposide—prostate cancer	0.000107	0.00112	CcSEcCtD
Diphenhydramine—Nausea—Conjugated Estrogens—prostate cancer	0.000106	0.00111	CcSEcCtD
Diphenhydramine—Urticaria—Mitoxantrone—prostate cancer	0.000106	0.00111	CcSEcCtD
Diphenhydramine—Anorexia—Etoposide—prostate cancer	0.000106	0.00111	CcSEcCtD
Diphenhydramine—Hypotension—Etoposide—prostate cancer	0.000104	0.00108	CcSEcCtD
Diphenhydramine—Vision blurred—Capecitabine—prostate cancer	0.000103	0.00108	CcSEcCtD
Diphenhydramine—Asthenia—Estradiol—prostate cancer	0.000103	0.00107	CcSEcCtD
Diphenhydramine—Tremor—Capecitabine—prostate cancer	0.000102	0.00107	CcSEcCtD
Diphenhydramine—Dysuria—Epirubicin—prostate cancer	0.000102	0.00107	CcSEcCtD
Diphenhydramine—Pollakiuria—Epirubicin—prostate cancer	0.000101	0.00106	CcSEcCtD
Diphenhydramine—Palpitations—Docetaxel—prostate cancer	9.97e-05	0.00104	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Epirubicin—prostate cancer	9.97e-05	0.00104	CcSEcCtD
Diphenhydramine—Paraesthesia—Etoposide—prostate cancer	9.95e-05	0.00104	CcSEcCtD
Diphenhydramine—Somnolence—Etoposide—prostate cancer	9.85e-05	0.00103	CcSEcCtD
Diphenhydramine—Vertigo—Capecitabine—prostate cancer	9.82e-05	0.00103	CcSEcCtD
Diphenhydramine—Diarrhoea—Estradiol—prostate cancer	9.78e-05	0.00102	CcSEcCtD
Diphenhydramine—Convulsion—Docetaxel—prostate cancer	9.78e-05	0.00102	CcSEcCtD
Diphenhydramine—Drowsiness—Epirubicin—prostate cancer	9.74e-05	0.00102	CcSEcCtD
Diphenhydramine—Palpitations—Capecitabine—prostate cancer	9.66e-05	0.00101	CcSEcCtD
Diphenhydramine—Decreased appetite—Etoposide—prostate cancer	9.63e-05	0.00101	CcSEcCtD
Diphenhydramine—Asthenia—Mitoxantrone—prostate cancer	9.56e-05	0.001	CcSEcCtD
Diphenhydramine—Fatigue—Etoposide—prostate cancer	9.56e-05	0.001	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Epirubicin—prostate cancer	9.55e-05	0.000999	CcSEcCtD
Diphenhydramine—Warfarin—CYP2C18—prostate cancer	9.53e-05	0.0221	CrCbGaD
Diphenhydramine—Constipation—Etoposide—prostate cancer	9.48e-05	0.000992	CcSEcCtD
Diphenhydramine—Dizziness—Estradiol—prostate cancer	9.46e-05	0.00099	CcSEcCtD
Diphenhydramine—Dysuria—Doxorubicin—prostate cancer	9.45e-05	0.000989	CcSEcCtD
Diphenhydramine—Dry mouth—Docetaxel—prostate cancer	9.4e-05	0.000983	CcSEcCtD
Diphenhydramine—Pollakiuria—Doxorubicin—prostate cancer	9.34e-05	0.000977	CcSEcCtD
Diphenhydramine—Confusional state—Docetaxel—prostate cancer	9.29e-05	0.000972	CcSEcCtD
Diphenhydramine—Bedaquiline—CYP3A4—prostate cancer	9.23e-05	0.0214	CrCbGaD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—prostate cancer	9.23e-05	0.000966	CcSEcCtD
Diphenhydramine—Vision blurred—Prednisone—prostate cancer	9.17e-05	0.00096	CcSEcCtD
Diphenhydramine—Feeling abnormal—Etoposide—prostate cancer	9.13e-05	0.000956	CcSEcCtD
Diphenhydramine—Diarrhoea—Mitoxantrone—prostate cancer	9.12e-05	0.000954	CcSEcCtD
Diphenhydramine—Dry mouth—Capecitabine—prostate cancer	9.1e-05	0.000952	CcSEcCtD
Diphenhydramine—Vomiting—Estradiol—prostate cancer	9.09e-05	0.000952	CcSEcCtD
Diphenhydramine—Agranulocytosis—Epirubicin—prostate cancer	9.09e-05	0.000951	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Docetaxel—prostate cancer	9.02e-05	0.000944	CcSEcCtD
Diphenhydramine—Rash—Estradiol—prostate cancer	9.02e-05	0.000944	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—prostate cancer	9.01e-05	0.000943	CcSEcCtD
Diphenhydramine—Dermatitis—Estradiol—prostate cancer	9.01e-05	0.000943	CcSEcCtD
Diphenhydramine—Confusional state—Capecitabine—prostate cancer	8.99e-05	0.000941	CcSEcCtD
Diphenhydramine—Tachycardia—Docetaxel—prostate cancer	8.99e-05	0.000941	CcSEcCtD
Diphenhydramine—Headache—Estradiol—prostate cancer	8.96e-05	0.000938	CcSEcCtD
Diphenhydramine—Agitation—Prednisone—prostate cancer	8.94e-05	0.000936	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—prostate cancer	8.83e-05	0.000925	CcSEcCtD
Diphenhydramine—Urticaria—Etoposide—prostate cancer	8.8e-05	0.000921	CcSEcCtD
Diphenhydramine—Anorexia—Docetaxel—prostate cancer	8.78e-05	0.000919	CcSEcCtD
Diphenhydramine—Vertigo—Prednisone—prostate cancer	8.74e-05	0.000915	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Capecitabine—prostate cancer	8.73e-05	0.000914	CcSEcCtD
Diphenhydramine—Tachycardia—Capecitabine—prostate cancer	8.7e-05	0.000911	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Capecitabine—prostate cancer	8.62e-05	0.000902	CcSEcCtD
Diphenhydramine—Hypotension—Docetaxel—prostate cancer	8.61e-05	0.000901	CcSEcCtD
Diphenhydramine—Anorexia—Capecitabine—prostate cancer	8.5e-05	0.00089	CcSEcCtD
Diphenhydramine—Nausea—Estradiol—prostate cancer	8.49e-05	0.000889	CcSEcCtD
Diphenhydramine—Vomiting—Mitoxantrone—prostate cancer	8.47e-05	0.000887	CcSEcCtD
Diphenhydramine—Convulsion—Prednisone—prostate cancer	8.43e-05	0.000883	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—prostate cancer	8.41e-05	0.00088	CcSEcCtD
Diphenhydramine—Rash—Mitoxantrone—prostate cancer	8.4e-05	0.000879	CcSEcCtD
Diphenhydramine—Dermatitis—Mitoxantrone—prostate cancer	8.39e-05	0.000878	CcSEcCtD
Diphenhydramine—Headache—Mitoxantrone—prostate cancer	8.35e-05	0.000874	CcSEcCtD
Diphenhydramine—Hypotension—Capecitabine—prostate cancer	8.33e-05	0.000872	CcSEcCtD
Diphenhydramine—Insomnia—Docetaxel—prostate cancer	8.33e-05	0.000872	CcSEcCtD
Diphenhydramine—Paraesthesia—Docetaxel—prostate cancer	8.27e-05	0.000866	CcSEcCtD
Diphenhydramine—Somnolence—Docetaxel—prostate cancer	8.19e-05	0.000857	CcSEcCtD
Diphenhydramine—Tinnitus—Epirubicin—prostate cancer	8.15e-05	0.000853	CcSEcCtD
Diphenhydramine—Dyspepsia—Docetaxel—prostate cancer	8.11e-05	0.000849	CcSEcCtD
Diphenhydramine—Insomnia—Capecitabine—prostate cancer	8.07e-05	0.000844	CcSEcCtD
Diphenhydramine—Paraesthesia—Capecitabine—prostate cancer	8.01e-05	0.000838	CcSEcCtD
Diphenhydramine—Decreased appetite—Docetaxel—prostate cancer	8.01e-05	0.000838	CcSEcCtD
Diphenhydramine—Asthenia—Etoposide—prostate cancer	7.95e-05	0.000832	CcSEcCtD
Diphenhydramine—Fatigue—Docetaxel—prostate cancer	7.94e-05	0.000831	CcSEcCtD
Diphenhydramine—Nausea—Mitoxantrone—prostate cancer	7.91e-05	0.000828	CcSEcCtD
Diphenhydramine—Constipation—Docetaxel—prostate cancer	7.88e-05	0.000824	CcSEcCtD
Diphenhydramine—Dyspepsia—Capecitabine—prostate cancer	7.85e-05	0.000822	CcSEcCtD
Diphenhydramine—Chills—Epirubicin—prostate cancer	7.85e-05	0.000821	CcSEcCtD
Diphenhydramine—Tachycardia—Prednisone—prostate cancer	7.75e-05	0.000811	CcSEcCtD
Diphenhydramine—Decreased appetite—Capecitabine—prostate cancer	7.75e-05	0.000811	CcSEcCtD
Diphenhydramine—Fatigue—Capecitabine—prostate cancer	7.69e-05	0.000805	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Prednisone—prostate cancer	7.68e-05	0.000804	CcSEcCtD
Diphenhydramine—Constipation—Capecitabine—prostate cancer	7.63e-05	0.000798	CcSEcCtD
Diphenhydramine—Feeling abnormal—Docetaxel—prostate cancer	7.59e-05	0.000794	CcSEcCtD
Diphenhydramine—Diarrhoea—Etoposide—prostate cancer	7.58e-05	0.000794	CcSEcCtD
Diphenhydramine—Anorexia—Prednisone—prostate cancer	7.57e-05	0.000792	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—prostate cancer	7.54e-05	0.00079	CcSEcCtD
Diphenhydramine—Tension—Epirubicin—prostate cancer	7.47e-05	0.000782	CcSEcCtD
Diphenhydramine—Nervousness—Epirubicin—prostate cancer	7.39e-05	0.000774	CcSEcCtD
Diphenhydramine—Toremifene—ESR1—prostate cancer	7.39e-05	0.0171	CrCbGaD
Diphenhydramine—Phenoxybenzamine—SLC22A3—prostate cancer	7.36e-05	0.0171	CrCbGaD
Diphenhydramine—Feeling abnormal—Capecitabine—prostate cancer	7.35e-05	0.000769	CcSEcCtD
Diphenhydramine—Dizziness—Etoposide—prostate cancer	7.33e-05	0.000767	CcSEcCtD
Diphenhydramine—Clomifene—CYP2A6—prostate cancer	7.29e-05	0.0169	CrCbGaD
Diphenhydramine—Chills—Doxorubicin—prostate cancer	7.26e-05	0.00076	CcSEcCtD
Diphenhydramine—Bifonazole—CYP19A1—prostate cancer	7.21e-05	0.0167	CrCbGaD
Diphenhydramine—Insomnia—Prednisone—prostate cancer	7.18e-05	0.000752	CcSEcCtD
Diphenhydramine—Vision blurred—Epirubicin—prostate cancer	7.17e-05	0.000751	CcSEcCtD
Diphenhydramine—Paraesthesia—Prednisone—prostate cancer	7.13e-05	0.000747	CcSEcCtD
Diphenhydramine—Urticaria—Capecitabine—prostate cancer	7.08e-05	0.000741	CcSEcCtD
Diphenhydramine—Vomiting—Etoposide—prostate cancer	7.05e-05	0.000738	CcSEcCtD
Diphenhydramine—Agitation—Epirubicin—prostate cancer	7e-05	0.000732	CcSEcCtD
Diphenhydramine—Dyspepsia—Prednisone—prostate cancer	6.99e-05	0.000732	CcSEcCtD
Diphenhydramine—Rash—Etoposide—prostate cancer	6.99e-05	0.000731	CcSEcCtD
Diphenhydramine—Dermatitis—Etoposide—prostate cancer	6.98e-05	0.000731	CcSEcCtD
Diphenhydramine—Headache—Etoposide—prostate cancer	6.94e-05	0.000727	CcSEcCtD
Diphenhydramine—Clomifene—CYP19A1—prostate cancer	6.94e-05	0.0161	CrCbGaD
Diphenhydramine—Phenytoin—CYP2C18—prostate cancer	6.92e-05	0.0161	CrCbGaD
Diphenhydramine—Tension—Doxorubicin—prostate cancer	6.91e-05	0.000723	CcSEcCtD
Diphenhydramine—Decreased appetite—Prednisone—prostate cancer	6.91e-05	0.000723	CcSEcCtD
Diphenhydramine—Fatigue—Prednisone—prostate cancer	6.85e-05	0.000717	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—prostate cancer	6.84e-05	0.000716	CcSEcCtD
Diphenhydramine—Vertigo—Epirubicin—prostate cancer	6.84e-05	0.000716	CcSEcCtD
Diphenhydramine—Constipation—Prednisone—prostate cancer	6.79e-05	0.000711	CcSEcCtD
Diphenhydramine—Palpitations—Epirubicin—prostate cancer	6.73e-05	0.000704	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—prostate cancer	6.64e-05	0.000695	CcSEcCtD
Diphenhydramine—Asthenia—Docetaxel—prostate cancer	6.61e-05	0.000692	CcSEcCtD
Diphenhydramine—Convulsion—Epirubicin—prostate cancer	6.6e-05	0.00069	CcSEcCtD
Diphenhydramine—Nausea—Etoposide—prostate cancer	6.58e-05	0.000689	CcSEcCtD
Diphenhydramine—Feeling abnormal—Prednisone—prostate cancer	6.55e-05	0.000685	CcSEcCtD
Diphenhydramine—Chlorphenamine—SLC22A1—prostate cancer	6.53e-05	0.0151	CrCbGaD
Diphenhydramine—Agitation—Doxorubicin—prostate cancer	6.47e-05	0.000677	CcSEcCtD
Diphenhydramine—Asthenia—Capecitabine—prostate cancer	6.4e-05	0.00067	CcSEcCtD
Diphenhydramine—Clomifene—ESR1—prostate cancer	6.39e-05	0.0148	CrCbGaD
Diphenhydramine—Dry mouth—Epirubicin—prostate cancer	6.34e-05	0.000663	CcSEcCtD
Diphenhydramine—Vertigo—Doxorubicin—prostate cancer	6.33e-05	0.000662	CcSEcCtD
Diphenhydramine—Urticaria—Prednisone—prostate cancer	6.31e-05	0.00066	CcSEcCtD
Diphenhydramine—Diarrhoea—Docetaxel—prostate cancer	6.3e-05	0.00066	CcSEcCtD
Diphenhydramine—Confusional state—Epirubicin—prostate cancer	6.26e-05	0.000656	CcSEcCtD
Diphenhydramine—Palpitations—Doxorubicin—prostate cancer	6.22e-05	0.000651	CcSEcCtD
Diphenhydramine—Convulsion—Doxorubicin—prostate cancer	6.1e-05	0.000639	CcSEcCtD
Diphenhydramine—Diarrhoea—Capecitabine—prostate cancer	6.1e-05	0.000639	CcSEcCtD
Diphenhydramine—Dizziness—Docetaxel—prostate cancer	6.09e-05	0.000637	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Epirubicin—prostate cancer	6.08e-05	0.000637	CcSEcCtD
Diphenhydramine—Tachycardia—Epirubicin—prostate cancer	6.06e-05	0.000635	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Epirubicin—prostate cancer	6.01e-05	0.000629	CcSEcCtD
Diphenhydramine—Anorexia—Epirubicin—prostate cancer	5.92e-05	0.00062	CcSEcCtD
Diphenhydramine—Toremifene—CYP1A1—prostate cancer	5.91e-05	0.0137	CrCbGaD
Diphenhydramine—Dizziness—Capecitabine—prostate cancer	5.9e-05	0.000617	CcSEcCtD
Diphenhydramine—Levomethadyl Acetate—CYP3A5—prostate cancer	5.88e-05	0.0137	CrCbGaD
Diphenhydramine—Dry mouth—Doxorubicin—prostate cancer	5.86e-05	0.000614	CcSEcCtD
Diphenhydramine—Vomiting—Docetaxel—prostate cancer	5.86e-05	0.000613	CcSEcCtD
Diphenhydramine—Rash—Docetaxel—prostate cancer	5.81e-05	0.000608	CcSEcCtD
Diphenhydramine—Hypotension—Epirubicin—prostate cancer	5.81e-05	0.000608	CcSEcCtD
Diphenhydramine—Dermatitis—Docetaxel—prostate cancer	5.8e-05	0.000607	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—prostate cancer	5.8e-05	0.000607	CcSEcCtD
Diphenhydramine—Headache—Docetaxel—prostate cancer	5.77e-05	0.000604	CcSEcCtD
Diphenhydramine—Asthenia—Prednisone—prostate cancer	5.7e-05	0.000596	CcSEcCtD
Diphenhydramine—Vomiting—Capecitabine—prostate cancer	5.67e-05	0.000593	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Doxorubicin—prostate cancer	5.63e-05	0.000589	CcSEcCtD
Diphenhydramine—Rash—Capecitabine—prostate cancer	5.62e-05	0.000588	CcSEcCtD
Diphenhydramine—Insomnia—Epirubicin—prostate cancer	5.62e-05	0.000588	CcSEcCtD
Diphenhydramine—Dermatitis—Capecitabine—prostate cancer	5.62e-05	0.000588	CcSEcCtD
Diphenhydramine—Tachycardia—Doxorubicin—prostate cancer	5.61e-05	0.000587	CcSEcCtD
Diphenhydramine—Headache—Capecitabine—prostate cancer	5.59e-05	0.000585	CcSEcCtD
Diphenhydramine—Paraesthesia—Epirubicin—prostate cancer	5.58e-05	0.000584	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Doxorubicin—prostate cancer	5.56e-05	0.000582	CcSEcCtD
Diphenhydramine—Somnolence—Epirubicin—prostate cancer	5.52e-05	0.000578	CcSEcCtD
Diphenhydramine—Anorexia—Doxorubicin—prostate cancer	5.48e-05	0.000573	CcSEcCtD
Diphenhydramine—Nausea—Docetaxel—prostate cancer	5.47e-05	0.000573	CcSEcCtD
Diphenhydramine—Dyspepsia—Epirubicin—prostate cancer	5.47e-05	0.000572	CcSEcCtD
Diphenhydramine—Diarrhoea—Prednisone—prostate cancer	5.44e-05	0.000569	CcSEcCtD
Diphenhydramine—Levomethadyl Acetate—CYP19A1—prostate cancer	5.42e-05	0.0126	CrCbGaD
Diphenhydramine—Decreased appetite—Epirubicin—prostate cancer	5.4e-05	0.000565	CcSEcCtD
Diphenhydramine—Bifonazole—CYP2E1—prostate cancer	5.38e-05	0.0125	CrCbGaD
Diphenhydramine—Hypotension—Doxorubicin—prostate cancer	5.37e-05	0.000562	CcSEcCtD
Diphenhydramine—Fatigue—Epirubicin—prostate cancer	5.36e-05	0.000561	CcSEcCtD
Diphenhydramine—Bifonazole—CYP2C19—prostate cancer	5.33e-05	0.0124	CrCbGaD
Diphenhydramine—Constipation—Epirubicin—prostate cancer	5.31e-05	0.000556	CcSEcCtD
Diphenhydramine—Nausea—Capecitabine—prostate cancer	5.3e-05	0.000554	CcSEcCtD
Diphenhydramine—Phenoxybenzamine—SLC22A1—prostate cancer	5.28e-05	0.0123	CrCbGaD
Diphenhydramine—Chlorphenamine—CYP3A5—prostate cancer	5.27e-05	0.0122	CrCbGaD
Diphenhydramine—Dizziness—Prednisone—prostate cancer	5.25e-05	0.00055	CcSEcCtD
Diphenhydramine—Methadone—CYP2C18—prostate cancer	5.24e-05	0.0121	CrCbGaD
Diphenhydramine—Insomnia—Doxorubicin—prostate cancer	5.2e-05	0.000544	CcSEcCtD
Diphenhydramine—Clomifene—CYP2E1—prostate cancer	5.17e-05	0.012	CrCbGaD
Diphenhydramine—Paraesthesia—Doxorubicin—prostate cancer	5.16e-05	0.00054	CcSEcCtD
Diphenhydramine—Modafinil—CYP3A5—prostate cancer	5.14e-05	0.0119	CrCbGaD
Diphenhydramine—Feeling abnormal—Epirubicin—prostate cancer	5.12e-05	0.000536	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—prostate cancer	5.11e-05	0.000535	CcSEcCtD
Diphenhydramine—Clomifene—CYP1A1—prostate cancer	5.1e-05	0.0118	CrCbGaD
Diphenhydramine—Dyspepsia—Doxorubicin—prostate cancer	5.06e-05	0.00053	CcSEcCtD
Diphenhydramine—Vomiting—Prednisone—prostate cancer	5.05e-05	0.000529	CcSEcCtD
Diphenhydramine—Fentanyl—CYP3A5—prostate cancer	5.03e-05	0.0117	CrCbGaD
Diphenhydramine—Rash—Prednisone—prostate cancer	5.01e-05	0.000524	CcSEcCtD
Diphenhydramine—Dermatitis—Prednisone—prostate cancer	5e-05	0.000524	CcSEcCtD
Diphenhydramine—Decreased appetite—Doxorubicin—prostate cancer	5e-05	0.000523	CcSEcCtD
Diphenhydramine—Headache—Prednisone—prostate cancer	4.98e-05	0.000521	CcSEcCtD
Diphenhydramine—Fatigue—Doxorubicin—prostate cancer	4.96e-05	0.000519	CcSEcCtD
Diphenhydramine—Urticaria—Epirubicin—prostate cancer	4.94e-05	0.000517	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—prostate cancer	4.92e-05	0.000514	CcSEcCtD
Diphenhydramine—Cinnarizine—CYP2A6—prostate cancer	4.82e-05	0.0112	CrCbGaD
Diphenhydramine—Tamoxifen—ESR2—prostate cancer	4.79e-05	0.0111	CrCbGaD
Diphenhydramine—Reboxetine—CYP3A4—prostate cancer	4.75e-05	0.011	CrCbGaD
Diphenhydramine—Feeling abnormal—Doxorubicin—prostate cancer	4.74e-05	0.000496	CcSEcCtD
Diphenhydramine—Benzatropine—CYP2C19—prostate cancer	4.73e-05	0.011	CrCbGaD
Diphenhydramine—Nausea—Prednisone—prostate cancer	4.72e-05	0.000494	CcSEcCtD
Diphenhydramine—Imipramine—SLC22A3—prostate cancer	4.66e-05	0.0108	CrCbGaD
Diphenhydramine—Urticaria—Doxorubicin—prostate cancer	4.57e-05	0.000478	CcSEcCtD
Diphenhydramine—Phenytoin—CYP3A5—prostate cancer	4.56e-05	0.0106	CrCbGaD
Diphenhydramine—Asthenia—Epirubicin—prostate cancer	4.46e-05	0.000467	CcSEcCtD
Diphenhydramine—Tamoxifen—CYP1B1—prostate cancer	4.37e-05	0.0101	CrCbGaD
Diphenhydramine—Warfarin—CYP2C19—prostate cancer	4.27e-05	0.00992	CrCbGaD
Diphenhydramine—Warfarin—CYP1A1—prostate cancer	4.26e-05	0.00988	CrCbGaD
Diphenhydramine—Carbinoxamine—CYP2E1—prostate cancer	4.26e-05	0.00987	CrCbGaD
Diphenhydramine—Diarrhoea—Epirubicin—prostate cancer	4.25e-05	0.000445	CcSEcCtD
Diphenhydramine—Carbinoxamine—CYP2C19—prostate cancer	4.22e-05	0.00978	CrCbGaD
Diphenhydramine—Oxaprozin—PTGS2—prostate cancer	4.21e-05	0.00977	CrCbGaD
Diphenhydramine—Asthenia—Doxorubicin—prostate cancer	4.12e-05	0.000432	CcSEcCtD
Diphenhydramine—Dizziness—Epirubicin—prostate cancer	4.11e-05	0.00043	CcSEcCtD
Diphenhydramine—Imipramine—CYP2C18—prostate cancer	4.1e-05	0.0095	CrCbGaD
Diphenhydramine—Vomiting—Epirubicin—prostate cancer	3.95e-05	0.000413	CcSEcCtD
Diphenhydramine—Diarrhoea—Doxorubicin—prostate cancer	3.93e-05	0.000412	CcSEcCtD
Diphenhydramine—Rash—Epirubicin—prostate cancer	3.92e-05	0.00041	CcSEcCtD
Diphenhydramine—Dermatitis—Epirubicin—prostate cancer	3.91e-05	0.00041	CcSEcCtD
Diphenhydramine—Headache—Epirubicin—prostate cancer	3.89e-05	0.000407	CcSEcCtD
Diphenhydramine—Dizziness—Doxorubicin—prostate cancer	3.8e-05	0.000398	CcSEcCtD
Diphenhydramine—Toremifene—CYP3A4—prostate cancer	3.77e-05	0.00875	CrCbGaD
Diphenhydramine—Nausea—Epirubicin—prostate cancer	3.69e-05	0.000386	CcSEcCtD
Diphenhydramine—Brompheniramine—CYP2E1—prostate cancer	3.69e-05	0.00855	CrCbGaD
Diphenhydramine—Vomiting—Doxorubicin—prostate cancer	3.65e-05	0.000383	CcSEcCtD
Diphenhydramine—Brompheniramine—CYP2C19—prostate cancer	3.65e-05	0.00847	CrCbGaD
Diphenhydramine—Rash—Doxorubicin—prostate cancer	3.62e-05	0.000379	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—prostate cancer	3.62e-05	0.000379	CcSEcCtD
Diphenhydramine—Headache—Doxorubicin—prostate cancer	3.6e-05	0.000377	CcSEcCtD
Diphenhydramine—Alimemazine—CYP3A4—prostate cancer	3.54e-05	0.00821	CrCbGaD
Diphenhydramine—Modafinil—CYP2C19—prostate cancer	3.5e-05	0.00812	CrCbGaD
Diphenhydramine—Tamoxifen—CYP3A5—prostate cancer	3.48e-05	0.00807	CrCbGaD
Diphenhydramine—Fenoprofen—PTGS2—prostate cancer	3.48e-05	0.00807	CrCbGaD
Diphenhydramine—Methadone—CYP3A5—prostate cancer	3.45e-05	0.008	CrCbGaD
Diphenhydramine—Nausea—Doxorubicin—prostate cancer	3.41e-05	0.000357	CcSEcCtD
Diphenhydramine—Bifonazole—CYP3A4—prostate cancer	3.39e-05	0.00786	CrCbGaD
Diphenhydramine—Cinnarizine—CYP1A1—prostate cancer	3.37e-05	0.00783	CrCbGaD
Diphenhydramine—Phenoxybenzamine—ADRB2—prostate cancer	3.37e-05	0.00782	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2A6—prostate cancer	3.37e-05	0.00781	CrCbGaD
Diphenhydramine—Imipramine—SLC22A1—prostate cancer	3.34e-05	0.00776	CrCbGaD
Diphenhydramine—Clomifene—CYP3A4—prostate cancer	3.26e-05	0.00756	CrCbGaD
Diphenhydramine—Cyclobenzaprine—CYP3A4—prostate cancer	3.26e-05	0.00756	CrCbGaD
Diphenhydramine—Tamoxifen—CYP19A1—prostate cancer	3.21e-05	0.00744	CrCbGaD
Diphenhydramine—Methadone—CYP19A1—prostate cancer	3.18e-05	0.00738	CrCbGaD
Diphenhydramine—Phenytoin—CYP2C19—prostate cancer	3.1e-05	0.0072	CrCbGaD
Diphenhydramine—Phenprocoumon—CYP3A4—prostate cancer	3.06e-05	0.00711	CrCbGaD
Diphenhydramine—Atomoxetine—CYP2C19—prostate cancer	3.01e-05	0.00699	CrCbGaD
Diphenhydramine—Tamoxifen—ESR1—prostate cancer	2.95e-05	0.00685	CrCbGaD
Diphenhydramine—Phenylbutazone—CYP3A4—prostate cancer	2.84e-05	0.00659	CrCbGaD
Diphenhydramine—Phenylbutazone—PTGS2—prostate cancer	2.78e-05	0.00646	CrCbGaD
Diphenhydramine—Warfarin—CYP3A4—prostate cancer	2.72e-05	0.00631	CrCbGaD
Diphenhydramine—Amitriptyline—CYP3A5—prostate cancer	2.68e-05	0.00622	CrCbGaD
Diphenhydramine—Carbinoxamine—CYP3A4—prostate cancer	2.68e-05	0.00622	CrCbGaD
Diphenhydramine—Levomethadyl Acetate—CYP3A4—prostate cancer	2.55e-05	0.00591	CrCbGaD
Diphenhydramine—Trimipramine—CYP2C19—prostate cancer	2.48e-05	0.00575	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2E1—prostate cancer	2.39e-05	0.00555	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2C19—prostate cancer	2.37e-05	0.00549	CrCbGaD
Diphenhydramine—Doxepin—CYP2C19—prostate cancer	2.36e-05	0.00548	CrCbGaD
Diphenhydramine—Tamoxifen—CYP1A1—prostate cancer	2.36e-05	0.00547	CrCbGaD
Diphenhydramine—Methadone—CYP2C19—prostate cancer	2.35e-05	0.00545	CrCbGaD
Diphenhydramine—Orphenadrine—CYP2E1—prostate cancer	2.32e-05	0.00539	CrCbGaD
Diphenhydramine—Brompheniramine—CYP3A4—prostate cancer	2.32e-05	0.00539	CrCbGaD
Diphenhydramine—Chlorphenamine—CYP3A4—prostate cancer	2.28e-05	0.00529	CrCbGaD
Diphenhydramine—Modafinil—CYP3A4—prostate cancer	2.23e-05	0.00516	CrCbGaD
Diphenhydramine—Dextropropoxyphene—CYP3A4—prostate cancer	2.2e-05	0.00511	CrCbGaD
Diphenhydramine—Fentanyl—CYP3A4—prostate cancer	2.18e-05	0.00505	CrCbGaD
Diphenhydramine—Promazine—CYP2C19—prostate cancer	2.1e-05	0.00487	CrCbGaD
Diphenhydramine—Phenytoin—CYP3A4—prostate cancer	1.97e-05	0.00458	CrCbGaD
Diphenhydramine—Benzphetamine—CYP3A4—prostate cancer	1.93e-05	0.00448	CrCbGaD
Diphenhydramine—Atomoxetine—CYP3A4—prostate cancer	1.91e-05	0.00444	CrCbGaD
Diphenhydramine—Imipramine—CYP2E1—prostate cancer	1.85e-05	0.0043	CrCbGaD
Diphenhydramine—Phenoxybenzamine—CYP3A4—prostate cancer	1.84e-05	0.00428	CrCbGaD
Diphenhydramine—Amitriptyline—CYP2E1—prostate cancer	1.84e-05	0.00428	CrCbGaD
Diphenhydramine—Imipramine—CYP2C19—prostate cancer	1.84e-05	0.00426	CrCbGaD
Diphenhydramine—Amitriptyline—CYP2C19—prostate cancer	1.83e-05	0.00423	CrCbGaD
Diphenhydramine—Trimipramine—CYP3A4—prostate cancer	1.57e-05	0.00365	CrCbGaD
Diphenhydramine—Tamoxifen—CYP3A4—prostate cancer	1.51e-05	0.00349	CrCbGaD
Diphenhydramine—Doxepin—CYP3A4—prostate cancer	1.5e-05	0.00348	CrCbGaD
Diphenhydramine—Methadone—CYP3A4—prostate cancer	1.49e-05	0.00346	CrCbGaD
Diphenhydramine—Orphenadrine—CYP3A4—prostate cancer	1.46e-05	0.00339	CrCbGaD
Diphenhydramine—Promazine—CYP3A4—prostate cancer	1.33e-05	0.0031	CrCbGaD
Diphenhydramine—Imipramine—CYP3A4—prostate cancer	1.17e-05	0.00271	CrCbGaD
Diphenhydramine—Amitriptyline—CYP3A4—prostate cancer	1.16e-05	0.00269	CrCbGaD
Diphenhydramine—CYP2C19—Metabolism—COMT—prostate cancer	2.26e-06	2.17e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HIF1A—prostate cancer	2.25e-06	2.17e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTP1—prostate cancer	2.25e-06	2.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NCOA1—prostate cancer	2.25e-06	2.16e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CD—prostate cancer	2.24e-06	2.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.23e-06	2.15e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CAV1—prostate cancer	2.23e-06	2.14e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HIF1A—prostate cancer	2.22e-06	2.13e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.21e-06	2.13e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ITPR1—prostate cancer	2.21e-06	2.13e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—NOS3—prostate cancer	2.21e-06	2.12e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LEP—prostate cancer	2.2e-06	2.12e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CAV1—prostate cancer	2.18e-06	2.1e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.17e-06	2.09e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.17e-06	2.09e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LEP—prostate cancer	2.16e-06	2.08e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—RXRA—prostate cancer	2.15e-06	2.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KDR—prostate cancer	2.15e-06	2.07e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CAV1—prostate cancer	2.14e-06	2.06e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—RXRA—prostate cancer	2.14e-06	2.06e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.12e-06	2.04e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KDR—prostate cancer	2.12e-06	2.04e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—NOS3—prostate cancer	2.12e-06	2.04e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ESR1—prostate cancer	2.1e-06	2.02e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NQO1—prostate cancer	2.1e-06	2.02e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CB—prostate cancer	2.1e-06	2.02e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TYMS—prostate cancer	2.09e-06	2.01e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—prostate cancer	2.08e-06	2e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.08e-06	2e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—COMT—prostate cancer	2.08e-06	2e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TH—prostate cancer	2.07e-06	1.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—prostate cancer	2.07e-06	1.99e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ESR1—prostate cancer	2.07e-06	1.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—prostate cancer	2.06e-06	1.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—COMT—prostate cancer	2.06e-06	1.98e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.05e-06	1.98e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BAD—prostate cancer	2.05e-06	1.97e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—prostate cancer	2.05e-06	1.97e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.05e-06	1.97e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CB—prostate cancer	2.04e-06	1.96e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.04e-06	1.96e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ITPR1—prostate cancer	2.03e-06	1.96e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.03e-06	1.95e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—LPL—prostate cancer	2.03e-06	1.95e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—prostate cancer	2.02e-06	1.94e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BAD—prostate cancer	2.02e-06	1.94e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ITPR1—prostate cancer	2.02e-06	1.94e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.01e-06	1.94e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	1.98e-06	1.91e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APC—prostate cancer	1.98e-06	1.91e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.98e-06	1.91e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGF—prostate cancer	1.96e-06	1.89e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IRS1—prostate cancer	1.96e-06	1.89e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.96e-06	1.88e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CB—prostate cancer	1.96e-06	1.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	1.95e-06	1.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APC—prostate cancer	1.95e-06	1.88e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GGT1—prostate cancer	1.95e-06	1.88e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ERCC2—prostate cancer	1.94e-06	1.87e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—prostate cancer	1.94e-06	1.87e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGF—prostate cancer	1.93e-06	1.86e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IRS1—prostate cancer	1.93e-06	1.86e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—prostate cancer	1.93e-06	1.86e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TYMS—prostate cancer	1.92e-06	1.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—INS—prostate cancer	1.92e-06	1.85e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NCOA1—prostate cancer	1.92e-06	1.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TYMS—prostate cancer	1.9e-06	1.83e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GSK3B—prostate cancer	1.9e-06	1.83e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.9e-06	1.83e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.89e-06	1.82e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—prostate cancer	1.88e-06	1.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CREBBP—prostate cancer	1.88e-06	1.81e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—INS—prostate cancer	1.88e-06	1.81e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GSK3B—prostate cancer	1.87e-06	1.8e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—LPL—prostate cancer	1.86e-06	1.79e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—INS—prostate cancer	1.85e-06	1.78e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—LPL—prostate cancer	1.85e-06	1.78e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CREBBP—prostate cancer	1.84e-06	1.77e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—RXRA—prostate cancer	1.83e-06	1.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—prostate cancer	1.82e-06	1.76e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1—prostate cancer	1.82e-06	1.75e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTEN—prostate cancer	1.81e-06	1.75e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CREBBP—prostate cancer	1.81e-06	1.74e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—prostate cancer	1.81e-06	1.74e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.8e-06	1.73e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARA—prostate cancer	1.79e-06	1.72e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1—prostate cancer	1.79e-06	1.72e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.78e-06	1.72e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.78e-06	1.72e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.78e-06	1.72e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—prostate cancer	1.78e-06	1.71e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.78e-06	1.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ERCC2—prostate cancer	1.77e-06	1.7e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTEN—prostate cancer	1.76e-06	1.69e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—COMT—prostate cancer	1.76e-06	1.69e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	1.76e-06	1.69e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—prostate cancer	1.75e-06	1.69e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	1.74e-06	1.68e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—EP300—prostate cancer	1.73e-06	1.66e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	1.73e-06	1.66e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	1.73e-06	1.66e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	1.72e-06	1.66e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.72e-06	1.66e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	1.72e-06	1.65e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—prostate cancer	1.71e-06	1.64e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	1.7e-06	1.64e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	1.7e-06	1.63e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.69e-06	1.63e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTEN—prostate cancer	1.69e-06	1.63e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NOS3—prostate cancer	1.68e-06	1.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CAV1—prostate cancer	1.68e-06	1.62e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—prostate cancer	1.68e-06	1.62e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—EP300—prostate cancer	1.68e-06	1.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.68e-06	1.62e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGF2—prostate cancer	1.67e-06	1.61e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—prostate cancer	1.66e-06	1.6e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOS3—prostate cancer	1.65e-06	1.59e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARA—prostate cancer	1.65e-06	1.58e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGF2—prostate cancer	1.64e-06	1.58e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARA—prostate cancer	1.63e-06	1.57e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TYMS—prostate cancer	1.63e-06	1.57e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOS3—prostate cancer	1.62e-06	1.56e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—EP300—prostate cancer	1.61e-06	1.55e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.61e-06	1.55e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.61e-06	1.55e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JAK2—prostate cancer	1.6e-06	1.54e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—LPL—prostate cancer	1.58e-06	1.52e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JAK2—prostate cancer	1.57e-06	1.52e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—prostate cancer	1.57e-06	1.52e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	1.57e-06	1.51e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MDM2—prostate cancer	1.56e-06	1.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.55e-06	1.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CAV1—prostate cancer	1.55e-06	1.49e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	1.54e-06	1.49e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB2—prostate cancer	1.54e-06	1.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—prostate cancer	1.54e-06	1.48e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MDM2—prostate cancer	1.54e-06	1.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CAV1—prostate cancer	1.53e-06	1.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.53e-06	1.48e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.52e-06	1.47e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	1.52e-06	1.46e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB2—prostate cancer	1.52e-06	1.46e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	1.5e-06	1.44e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.47e-06	1.41e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—prostate cancer	1.46e-06	1.41e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—INS—prostate cancer	1.45e-06	1.4e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—prostate cancer	1.44e-06	1.38e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	1.43e-06	1.37e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.42e-06	1.37e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.42e-06	1.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	1.41e-06	1.36e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.41e-06	1.36e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	1.4e-06	1.35e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—prostate cancer	1.4e-06	1.35e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.4e-06	1.35e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2—prostate cancer	1.4e-06	1.34e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARA—prostate cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—prostate cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—prostate cancer	1.38e-06	1.32e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2—prostate cancer	1.37e-06	1.32e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—prostate cancer	1.37e-06	1.32e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—prostate cancer	1.36e-06	1.31e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	1.35e-06	1.3e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.35e-06	1.3e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTEN—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—prostate cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—INS—prostate cancer	1.33e-06	1.28e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	1.33e-06	1.28e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—INS—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTEN—prostate cancer	1.31e-06	1.26e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CAV1—prostate cancer	1.31e-06	1.26e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.31e-06	1.26e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.29e-06	1.24e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—EP300—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—prostate cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NOS3—prostate cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	1.26e-06	1.21e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EP300—prostate cancer	1.25e-06	1.21e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.25e-06	1.21e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—prostate cancer	1.24e-06	1.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.24e-06	1.19e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EP300—prostate cancer	1.23e-06	1.19e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SRC—prostate cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SRC—prostate cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.19e-06	1.15e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—prostate cancer	1.19e-06	1.15e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—prostate cancer	1.17e-06	1.13e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.17e-06	1.13e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NOS3—prostate cancer	1.17e-06	1.13e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NOS3—prostate cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—prostate cancer	1.16e-06	1.11e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—INS—prostate cancer	1.13e-06	1.09e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—prostate cancer	1.09e-06	1.05e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.09e-06	1.05e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—prostate cancer	1.07e-06	1.03e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	1.07e-06	1.03e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.07e-06	1.03e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.07e-06	1.03e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—prostate cancer	1.07e-06	1.03e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—prostate cancer	1.05e-06	1.01e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.05e-06	1.01e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—prostate cancer	1.04e-06	1.01e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTEN—prostate cancer	1.01e-06	9.77e-06	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—prostate cancer	1.01e-06	9.77e-06	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—prostate cancer	1.01e-06	9.71e-06	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—prostate cancer	9.92e-07	9.56e-06	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NOS3—prostate cancer	9.91e-07	9.54e-06	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—prostate cancer	9.74e-07	9.38e-06	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—EP300—prostate cancer	9.68e-07	9.32e-06	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—prostate cancer	9.47e-07	9.12e-06	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTEN—prostate cancer	9.33e-07	8.99e-06	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	9.27e-07	8.92e-06	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTEN—prostate cancer	9.25e-07	8.91e-06	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CB—prostate cancer	9.15e-07	8.81e-06	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	9.12e-07	8.78e-06	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—prostate cancer	9.07e-07	8.73e-06	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—prostate cancer	8.96e-07	8.63e-06	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—EP300—prostate cancer	8.9e-07	8.57e-06	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—EP300—prostate cancer	8.82e-07	8.5e-06	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—prostate cancer	8.82e-07	8.49e-06	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—prostate cancer	8.21e-07	7.9e-06	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—prostate cancer	8.07e-07	7.77e-06	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTEN—prostate cancer	7.91e-07	7.61e-06	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—prostate cancer	7.74e-07	7.45e-06	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—prostate cancer	7.57e-07	7.29e-06	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—EP300—prostate cancer	7.54e-07	7.26e-06	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—prostate cancer	7.45e-07	7.17e-06	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—prostate cancer	7.16e-07	6.89e-06	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.58e-07	6.34e-06	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.53e-07	6.29e-06	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—prostate cancer	5.85e-07	5.63e-06	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—prostate cancer	5.58e-07	5.37e-06	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—prostate cancer	5.38e-07	5.18e-06	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—prostate cancer	5.33e-07	5.13e-06	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—prostate cancer	4.56e-07	4.39e-06	CbGpPWpGaD
